|
NIPAL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.994170E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.644400E-03 |
| Normal-vs-Stage2 |
7.725000E-01 |
| Normal-vs-Stage3 |
1.150850E-01 |
| Normal-vs-Stage4 |
1.622620E-01 |
| Stage1-vs-Stage2 |
5.857900E-02 |
| Stage1-vs-Stage3 |
5.367000E-01 |
| Stage1-vs-Stage4 |
8.617000E-01 |
| Stage2-vs-Stage3 |
1.561180E-01 |
| Stage2-vs-Stage4 |
1.722170E-01 |
| Stage3-vs-Stage4 |
7.879200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.050170E-02 |
| Normal-vs-AfricanAmerican |
2.353200E-01 |
| Normal-vs-Asian |
3.718100E-02 |
| Caucasian-vs-AfricanAmerican |
9.710200E-01 |
| Caucasian-vs-Asian |
5.452200E-01 |
| AfricanAmerican-vs-Asian |
6.655000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.894400E-01 |
| Normal-vs-Female |
4.705000E-03 |
| Male-vs-Female |
2.111800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.544530E-03 |
| Normal-vs-Age(41-60Yrs) |
2.715200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.172400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.122400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.046200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.858100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.684000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.793000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.298200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.349600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.790600E-01 |
| Classical-VS-Follicular |
9.54079999448965E-08 |
| Classical-VS-Other |
3.830300E-02 |
| Classical-VS-Normal |
2.637100E-04 |
| Tall-VS-Follicular |
1.436570E-03 |
| Tall-VS-Other |
2.539700E-02 |
| Tall-VS-Normal |
3.878400E-02 |
| Follicular-VS-Other |
5.527800E-01 |
| Follicular-VS-Normal |
7.901900E-02 |
| Other-VS-Normal |
7.954200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.849400E-01 |
| Normal-vs-N1 |
8.863600E-02 |
| N0-vs-N1 |
9.804000E-02 |
|
|
